Skip to main content
. Author manuscript; available in PMC: 2010 Apr 1.
Published in final edited form as: Future Med Chem. 2009 Jun 1;1(3):501–513. doi: 10.4155/fmc.09.38

Figure 1.

Figure 1

Commonly used agents for dopamine-replacement therapy: 3,4-dihydroxy-L-phenylalanine (1), benserazide (2), bromocriptine (3), pergolide (4), ropinole (5), pramipexole (7), selegeline (8) and entacapone (9).